Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:selecta_biosciences [2023/02/03 18:58]
liam [History]
+++ pharmaceutical_companies:selecta_biosciences [2024/03/26 20:00] (current)
liam
@@ Line 7: / Line 7: @@
 ===== History =====
-Selecta Biosciences was founded in 2008 by [[:Omid Farokhzad]].((//Selecta Biosciences - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences)) The company was founded to develop [[:immunomodulation|immunomodulatory]] [[:nanoparticle|nanoparticles]] for the treatment and prevention of human diseases. Early investors in the then-private startup included [[:Polaris Partners]] and [[:Flagship Pioneering]], the latter of which would soon also launch [[Moderna]].((Bratzler, R. (2009, February 25). //Selecta Biosciences, Inc. Closes $15.1M Series B Financing.// Flagship Pioneering. http://archive.today/2023.02.03-174945/https://www.flagshippioneering.com/press/selecta-biosciences-inc-closes-151m-series-b-financing)) ((//Moderna.// Flagship Pioneering. Retrieved September 15, 2022, from http://archive.today/2022.09.15-150329/https://www.flagshippioneering.com/companies/moderna)) They were joined in February 2009 by additional investments from [[:NanoDimension]] and Professor [[:Timothy Springer]] (a founding investor in Moderna).((Tognini, G. (2020, May 16). //Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus.// Forbes. https://web.archive.org/web/20230203175707/https://www.forbes.com/sites/giacomotognini/2020/05/16/exclusive-harvard-professor-who-became-a-billionaire-thanks-to-moderna-talks-about-his-investing/?sh=5ac096b6b8d7))
+Selecta Biosciences was founded in 2008 by [[:Omid Farokhzad]], after its incorporation in 2007.((//Selecta Biosciences - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences)) ((//Selecta Biosciences, Inc. (SELB) Company Profile & Facts.// Yahoo Finance. Retrieved October 16, 2021, from https://web.archive.org/web/20211016161609/https://finance.yahoo.com/quote/SELB/profile?p=SELB)) The company was founded to develop [[:immunomodulation|immunomodulatory]] [[:nanoparticle|nanoparticles]] for the treatment and prevention of human diseases. Early investors in the then-private startup included [[:Polaris Partners]] and [[:Flagship Pioneering]], the latter of which would soon also launch [[Moderna]].((Bratzler, R. (2009, February 25). //Selecta Biosciences, Inc. Closes $15.1M Series B Financing.// Flagship Pioneering. http://archive.today/2023.02.03-174945/https://www.flagshippioneering.com/press/selecta-biosciences-inc-closes-151m-series-b-financing)) ((//Moderna.// Flagship Pioneering. Retrieved September 15, 2022, from http://archive.today/2022.09.15-150329/https://www.flagshippioneering.com/companies/moderna)) They were joined in February 2009 by additional investments from [[:NanoDimension]] and Professor [[:Timothy Springer]] (a founding investor in Moderna).((Tognini, G. (2020, May 16). //Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus.// Forbes. https://web.archive.org/web/20230203175707/https://www.forbes.com/sites/giacomotognini/2020/05/16/exclusive-harvard-professor-who-became-a-billionaire-thanks-to-moderna-talks-about-his-investing/?sh=5ac096b6b8d7))
 In December 2021, Selecta invested in a Series B funding round for [[Cyrus Biotechnology]].((//Selecta Biosciences - Funding, Financials, Valuation & Investors.// Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences/company_financials))
+===== Activities =====
+The company has had license and collaboration agreements with:((//Selecta Biosciences, Inc. (SELB) Company Profile & Facts.// Yahoo Finance. Retrieved October 16, 2021, from https://web.archive.org/web/20211016161609/https://finance.yahoo.com/quote/SELB/profile?p=SELB)) ((//Partnerships.// Selecta Biosciences. Retrieved October 13, 2022, from https://web.archive.org/web/20221013150325/https://selectabio.com/partnerships/))
+  * [[Asklepios BioPharmaceutical]] (AskBio)
+  * [[Gingko Bioworks]]
+  * [[IGAN Biosciences]]
+  * [[:Massachusetts Institute of Technology]] (MIT)
+  * [[Sarepta Therapeutics]]
+  * [[Shenyang Sunshine Pharmaceutical Co.]]
+  * [[Spark Therapeutics]]
+  * [[Swedish Orphan Biovitrum]] (Sobi)
+  * [[Takeda]]
+==== Patents ====
+^ Number  ^ Title  ^ Date filed  ^ Inventor(s)  ^
+| [[https://web.archive.org/web/20230204063213/https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2012149411|WO2012149411]]  | CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS  | April 27, 2012  | [[:David Altreuter]], [[Aaron Griset]], [[Roberto Maldonaldo]]  |
 ===== Organization =====
-^  Personnel  ^^^
+^  Personnel((//About Us.// Selecta Biosciences. Retrieved February 4, 2023, from https://archive.ph/Ntfgo))  ^^^
 ^ Name  ^ Position  ^ Notes  ^
+| [[:Carsten Brunn]]  | President and CEO  | [[Bayer]], [[:European Federation of Pharmaceutical Industries and Associations Japan]], [[Eli Lilly]], [[Novartis]], [[Basilea Pharmaceuticals]], [[:Bausch & Lomb]], [[Surface Oncology]]  |
+| [[:Lloyd Johnston]]  | Chief Operations Officer  | [[Alkermes]], [[Advanced Inhalation Research]] (AIR), [[:University of New South Wales]]  |
+| [[:Takeshi Kei Kishimoto]]  | Chief Science Officer  | [[Momenta Pharmaceuticals]], [[Millennium Pharmaceuticals]], [[Boehringer Ingelheim]]  |
+| [[:Kristen Baldwin]]  | Chief People Officer  | [[:LIVEKINDLY Collective]], [[:CEO.works]], [[Bayer]], [[Otsuka Pharmaceuticals]]  |
+| [[:Peter Traber]]  | Chief Medical Officer  | [[:Alacrita Consulting]], [[Morphic Therapeutic]], [[Galectin Therapeutics]], [[GlaxoSmithKline]], [[:Baylor College of Medicine]], [[:University of Pennsylvania Health System]], [[:University of Pennsylvania]], [[Caladrius Biosciences]]  |
+| [[:Blaine Davis]]  | Chief Financial Officer  | [[Protera Therapeutics]], [[Insmed]], [[Endo International]], [[:Endo Ventures]], [[Bristol-Myers Squibb]]  |
+| [[:Matthew Bartholomae]]  | General Counsel, Secretary  | [[Minerva Neurosciences]]  |
+| [[:Ann Donohue]]  | Vice President of Finance & Controller  | -  |
+| [[:Ulrich von Andrian]]  | Co-Founder and Co-Chair of the Scientific Advisory Board  | -  |
+| [[:Carrie Cox]]  | Chairman  | [[Humacyte]], [[Schering-Plough]], [[Pharmacia & Upjohn]], [[:Texas Instruments]], [[:Cardinal Health]], [[Organon]], [[Celgene]], [[Array BioPharma]], [[medical_technology_companies:electroCore]], [[Prism Pharmaceutical]]  |
+| [[:Timothy Barabe]]  | Director  | [[ArQule]], [[:Veeva Systems]], [[Vigilant Biosciences]], [[medical_technology_companies:Affymetrix]], [[Human Genome Sciences]], [[:Regent Medical]], [[Sandoz]]  |
+| [[:Nishan de Silva]]  | Director  | [[AFYX Therapeutics]], [[Poseida Therapeutics]], [[Ligand Pharmaceuticals]], [[:Warburg Pincus]], [[:McKinsey & Company]]  |
+| [[:Scott Myers]]  | Director  | [[AMAG Pharmaceuticals]], [[Rainier Therapeutics]], [[Cascadian Therapeutics]], [[Aerocrine]], [[UCB]], [[Johnson & Johnson]], [[Trillium Therapeutics]], [[Harpoon Therapeutics]], [[Dynavax]]  |
+| [[:Aymeric Sallin]]  | Director  | [[:NanoDimension]], [[:H55]], [[:Crocus Technology]], [[Tarveda Therapeutics]], [[:Swiss Academy of Engineering Science]], [[:École Polytechnique Fédérale de Lausanne]] (EPFL)  |
+| [[:Timothy Springer]]  | Director  | [[:Harvard Medical School]], [[:Boston Children's Hospital]], [[LeukoSite]], [[:National Academy of Sciences]]  |
+| [[:Patrick Zenner]]  | Director  | [[Roche]], [[ArQule]], [[:West Pharmaceutical Services]]  |
 | [[:Shuang Sarah Wu]]  | Senior Manager of Strategy and Business Development (former)((//SHUANG (SARAH) WU, Gerente Senior, Estrategia y Desarrollo de Negocios, Selecta Biosciences.// GetEmail.io. Retrieved February 3, 2023, from https://web.archive.org/web/20230203004058/https://b2b.getemail.io/shuang-sarah-wu-pfizer-person-company-21927493-3411511.html)) ((NOSTUPID3. (2023, January 31). //微博.// Weibo. https://archive.ph/WPywO))  | Now at [[Pfizer]]  |
@@ Line 47: / Line 82: @@
   * [[https://www.linkedin.com/company/selecta-bio/|LinkedIn]]
   * [[https://twitter.com/selectabio|Twitter]]
+  * [[https://wiki.whiteroseintelligence.com/en/Selecta-Biosciences|White Rose Wiki]]